What are the challenges of standardizing cannabinoid extracts for consistent therapeutic use?
What are the challenges of standardizing cannabinoid extracts for consistent therapeutic use? Standardizing cannabinoid extracts poses significant challenges, including variability in plant genetics, cultivation methods, and extraction techniques, all of which can affect the composition and potency of the final product. The lack of established manufacturing processes and quality control standards in the cannabis industry further complicates the standardization of extracts. Additionally, the presence of various cannabinoids, terpenes, and other phytochemicals can result in batch-to-batch inconsistencies, impacting therapeutic efficacy and safety. To address these challenges, regulatory frameworks and industry standards must be developed to ensure the consistency and quality of cannabinoid products. Collaborative efforts among researchers, manufacturers, and regulatory bodies are vital for achieving reliable and effective cannabinoid therapies (Hirschfeld et al., 2020).